Stanobolic – Stanozolol 100 mg/mL | 10 mL Vial
1. Product Overview
Stanobolic is presented as an injectable anabolic-androgenic steroid product containing stanozolol, a synthetic androgen structurally derived from dihydrotestosterone (DHT).
According to the supplied Roidsdeal short description, the product has a declared concentration of 100 mg/mL and is packaged in a 10 mL vial.
Based on these specifications, the calculated total active ingredient content is 1,000 mg per vial.
The supplied information identifies Nitro Labs as the manufacturer.
However, no original manufacturer label or independent documentation has been provided to confirm this identity.
Stanozolol belongs to the anabolic-androgenic steroid (AAS) class.
It is a synthetic androgen with pharmacological activity involving androgen receptor signaling and related physiological processes.
Stanozolol has a history of medical use in certain jurisdictions and clinical settings.
However, historical medical applications do not establish that this particular Stanobolic product is an authorized pharmaceutical preparation.
The supplied material does not identify whether the injectable formulation is a water-based suspension, an oil-based preparation, or another formulation type.
This distinction is important because different injectable formulations may have different physical characteristics, stability requirements, and safety considerations.
No Roidsdeal long description or Finest Gears description has been supplied for this product.
Accordingly, the declared ingredient, concentration, vial volume, and listed manufacturer are supported only by Roidsdeal’s short description.
The following information provides a general scientific overview of stanozolol while clearly distinguishing established compound-level information from unverified product-specific claims.
2. What Is Stanobolic?
Stanobolic is the commercial product name used for a stanozolol preparation described in the supplied Roidsdeal product data.
Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone.
Its chemical structure includes modifications that distinguish it from naturally occurring DHT and testosterone.
Stanozolol is classified as a 17-alpha-alkylated anabolic steroid.
This structural characteristic contributes to its pharmacological activity and is relevant to liver-related safety concerns.
Stanozolol has historically been marketed under the trade name Winstrol.
However, the use of the same active ingredient does not establish that Stanobolic is an original branded medication, an authorized generic, or a therapeutically equivalent pharmaceutical preparation.
Stanozolol has been produced in different dosage forms, including oral and injectable preparations.
The supplied Roidsdeal short description identifies Stanobolic as a 10 mL vial containing a declared 100 mg/mL concentration.
However, it does not identify the exact injectable formulation.
Therefore, the product should not automatically be described as water-based or oil-based without additional evidence.
Stanozolol interacts with androgen receptors and influences androgen-related biological processes.
It is not generally considered to undergo aromatization into estrogenic compounds.
Nevertheless, the absence of significant aromatization does not eliminate cardiovascular, endocrine, hepatic, reproductive, or androgenic risks.
3. How Does Stanozolol Work?
Stanozolol produces pharmacological effects through androgen-related pathways.
Androgen Receptor Activation
Stanozolol interacts with androgen receptors in hormone-responsive tissues.
These receptors regulate gene expression and participate in physiological processes involving muscle, bone, reproductive tissues, and endocrine function.
Dihydrotestosterone-Derived Structure
Stanozolol is structurally derived from DHT.
Its chemical modifications influence its pharmacological characteristics and distinguish it from testosterone and other anabolic steroids.
Anabolic-Androgenic Signaling
Stanozolol belongs to the anabolic-androgenic steroid class.
Its pharmacological activity involves pathways associated with androgen-responsive tissues and protein metabolism.
However, pharmacological activity does not establish the safety or medical appropriateness of nonprescribed use.
Aromatization Characteristics
Stanozolol is not generally considered an aromatizable androgen.
It does not typically undergo conversion into estrogenic metabolites through the aromatase pathway.
However, hormonal disturbances can still occur through endocrine feedback and other mechanisms.
Endocrine Feedback
Exogenous anabolic-androgenic steroid exposure can suppress the hypothalamic-pituitary-gonadal axis.
This may interfere with normal testosterone production and reproductive function.
Liver-Related Pharmacology
Stanozolol is a 17-alpha-alkylated anabolic steroid.
This chemical characteristic is associated with potentially serious hepatic adverse effects.
The presence of an injectable dosage form does not eliminate liver-related risks associated with the compound.
Formulation Considerations
The supplied data do not establish whether Stanobolic is a suspension, solution, or another injectable preparation.
Consequently, no reliable product-specific release profile or pharmacokinetic characteristics can be established from the available information.
4. Medical Uses & Clinical Information
Stanozolol has a history of medical use and scientific investigation.
However, these historical applications must be distinguished from current regulatory authorization for Stanobolic.
Historical Medical Applications
Stanozolol-containing preparations have historically been used in selected medical settings.
Their indications and regulatory status have varied by country and formulation.
Historical use does not establish current approval of the Stanobolic product.
Hereditary Angioedema
Stanozolol has historically been used in certain settings for the prevention of hereditary angioedema attacks.
However, treatment standards have evolved, and newer targeted therapies are available.
This historical application does not establish that Stanobolic is an authorized treatment.
Androgen Receptor Research
Stanozolol is relevant to research involving synthetic androgens and androgen receptor signaling.
Its pharmacological activity contributes to scientific understanding of anabolic-androgenic compounds.
Protein Metabolism Research
Anabolic-androgenic steroids can influence pathways associated with protein metabolism.
However, these biological effects do not establish that nonmedical use is safe or clinically appropriate.
Endocrine Research
Stanozolol is relevant to investigations involving hormonal feedback, androgen signaling, and reproductive endocrine function.
Exogenous anabolic steroid exposure can suppress endogenous hormone production.
Cardiovascular and Metabolic Considerations
Stanozolol exposure can adversely affect blood lipid profiles.
Potential changes include reduced HDL cholesterol and increased LDL cholesterol.
These changes may contribute to cardiovascular risk.
Hepatic Safety Research
Stanozolol is associated with liver-related adverse effects, including cholestatic injury and other serious hepatic complications.
Its 17-alpha-alkylated structure is particularly relevant to these concerns.
Performance-Enhancement Claims
Stanozolol is sometimes discussed in bodybuilding and athletic performance contexts.
However, nonmedical performance enhancement is not an established safe medical indication.
Stanozolol is prohibited in competitive sport under WADA regulations.
Clinical Limitations
No product-specific clinical studies evaluating Stanobolic have been supplied.
The available information does not establish its pharmaceutical equivalence to any authorized stanozolol preparation.
Therefore, historical medical research should not be interpreted as proof of the safety or effectiveness of this commercial product.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | Stanobolic |
| Brand | Not Confirmed |
| Listed Manufacturer | Nitro Labs |
| Manufacturer Verification | Required |
| Active Ingredient | Stanozolol |
| Historical Trade Name Reference | Winstrol |
| Compound Classification | Anabolic-Androgenic Steroid |
| Structural Classification | Dihydrotestosterone Derivative |
| Chemical Classification | 17-Alpha-Alkylated Steroid |
| Declared Concentration | 100 mg/mL |
| Dosage Form | Injectable Preparation |
| Declared Package Volume | 10 mL |
| Packaging Presentation | Vial |
| Calculated Total Active Content | 1,000 mg |
| Formulation Type | Not Specified |
| Carrier Oil / Aqueous Vehicle | Not Specified |
| Excipients | Not Specified |
| Product Category | Injectable Anabolic Steroids |
| Aromatization | Not Generally Considered Significant |
| US Controlled Substance Status | Schedule III |
| WADA Status | Prohibited |
| Product-Specific Regulatory Approval | Not Established |
| Batch-Specific COA | Not Provided |
| Sterility Testing | Not Provided |
| Actual Ingredient Concentration | Not Independently Verified |
| Manufacturing Quality | Not Independently Verified |
Roidsdeal’s short description identifies stanozolol as the active ingredient.
It also provides the declared concentration of 100 mg/mL and the 10 mL vial presentation.
However, the supplied material does not include a Roidsdeal long description or either Finest Gears description.
Therefore, there is no second source available to compare the ingredient, concentration, package volume, or manufacturer.
The exact formulation type is also unknown.
No batch-specific laboratory report, sterility testing, or independent analytical documentation has been supplied.
6. Administration & Medical Supervision
Stanobolic is described as an injectable stanozolol preparation.
However, the supplied documentation does not establish an approved human dosing regimen or authorized therapeutic indication for this specific product.
The declared 100 mg/mL concentration identifies the claimed amount of stanozolol per milliliter.
It does not represent a recommended or medically appropriate dose.
No injection procedure, administration schedule, bodybuilding cycle, or performance-enhancement regimen is supported by the supplied information.
The exact injectable formulation has not been identified.
This is a significant limitation because injectable suspensions and solutions may differ in their physical characteristics and stability requirements.
Medical evaluation of anabolic steroid exposure may involve liver function, lipid measurements, cardiovascular health, and endocrine function.
The actual ingredient content, formulation, sterility, and pharmaceutical quality of this commercial product have not been independently verified.
It should not be assumed suitable for human injection based solely on the supplied short description.
7. Possible Side Effects & Safety Limitations
Stanozolol can produce significant adverse effects associated with anabolic-androgenic steroid exposure.
Liver-Related Adverse Effects
Potential hepatic complications include:
- Elevated liver enzymes
- Cholestatic liver injury
- Jaundice
- Liver dysfunction
- Peliosis hepatis
- Hepatic tumors associated with anabolic steroid exposure
Cardiovascular and Metabolic Effects
Potential complications include:
- Reduced HDL cholesterol
- Increased LDL cholesterol
- Elevated cardiovascular risk
- Blood pressure-related concerns
- Other metabolic effects associated with androgen exposure
Endocrine and Reproductive Effects
Potential adverse effects include:
- Suppression of endogenous testosterone production
- Reduced fertility
- Testicular atrophy
- Changes in libido
- Menstrual disturbances
- Virilization in females
- Other hormonal imbalances
Androgenic Effects
Potential androgen-related effects include:
- Acne
- Oily skin
- Hair loss in susceptible individuals
- Increased body or facial hair growth
- Prostate-related concerns in susceptible individuals
Effects in Females
Stanozolol can cause virilization.
Potential effects include voice deepening, increased facial hair, menstrual changes, and other androgenic characteristics.
Some changes may be irreversible.
Psychological and Behavioral Effects
Anabolic steroid exposure may be associated with mood disturbances, irritability, or other behavioral changes.
Injectable Formulation Risks
Unverified injectable preparations may introduce additional risks involving:
- Microbial contamination
- Injection-site infection
- Incorrect active ingredient concentrations
- Undisclosed formulation ingredients
- Formulation instability
- Sterility failures
The actual frequency and severity of adverse effects for this specific Stanobolic product have not been established.
8. Warnings & Precautions
Stanozolol is a pharmacologically active anabolic-androgenic steroid.
Its 17-alpha-alkylated structure is associated with clinically important liver toxicity risks.
Individuals with existing liver disease, cardiovascular conditions, abnormal blood lipid profiles, endocrine disorders, or reproductive-health concerns may face additional risks.
Exogenous androgen exposure can suppress natural hormone production and interfere with fertility.
Exposure during pregnancy may cause serious developmental harm.
Anabolic-androgenic steroids can cause virilization in females and interfere with normal development in adolescents.
Stanozolol is prohibited in competitive sport under WADA regulations.
In the United States, stanozolol is classified as a Schedule III controlled anabolic steroid.
The supplied description does not establish that Stanobolic is an authorized pharmaceutical preparation.
Product identity, actual concentration, formulation, sterility, manufacturing quality, and regulatory authorization require independent verification.
9. Storage & Handling
Stanobolic is described as a 10 mL vial product.
The supplied information does not provide verified manufacturer-specific storage temperatures, stability data, or expiration requirements.
Storage conditions for injectable preparations depend on the exact formulation, excipients, container closure system, and manufacturing process.
These details are not supplied.
Storage should follow authentic manufacturer labeling when available.
The product should remain in its original, clearly identified packaging.
Avoid environmental conditions that may compromise formulation stability or packaging integrity.
Keep the product away from children and unauthorized access.
A vial with damaged packaging, compromised seals, uncertain labeling, or unverified storage history should not be assumed safe for administration.
No product-specific in-use stability information has been supplied.
10. Frequently Asked Questions (FAQs)
What is Stanobolic?
Stanobolic is a product described by Roidsdeal as containing stanozolol, a synthetic anabolic-androgenic steroid derived from dihydrotestosterone.
What is the declared concentration?
Roidsdeal lists a concentration of 100 mg/mL. The actual concentration has not been independently verified.
What is the package size?
Roidsdeal identifies a 10 mL vial.
Is Stanobolic water-based or oil-based?
The supplied information does not specify the formulation type. The carrier vehicle and physical characteristics require manufacturer verification.
Is Stanobolic an FDA-approved medication?
No FDA approval has been established for Stanobolic. Historical medical use of stanozolol does not establish regulatory authorization for this specific commercial product.
11. Conclusion & Medical Disclaimer
Stanobolic is presented as an injectable anabolic-androgenic steroid preparation containing a declared 100 mg/mL of stanozolol in a 10 mL vial.
Stanozolol is a synthetic DHT-derived androgen with pharmacological activity involving androgen receptor signaling and related endocrine processes.
It has a history of medical use in selected settings.
However, the supplied information does not establish current medical authorization for this specific Stanobolic product.
Roidsdeal’s short description identifies the active ingredient, concentration, vial volume, and listed manufacturer.
No additional product descriptions are available from Roidsdeal or Finest Gears.
The exact formulation type, brand identity, manufacturer authenticity, actual ingredient concentration, sterility, and manufacturing quality remain unverified.
These limitations are particularly important because the product is described as an injectable preparation.
Medical Disclaimer: This information is provided for educational and product-identification purposes only. It does not constitute medical advice, injection guidance, dosage recommendations, or a recommendation for nonmedical anabolic steroid use, bodybuilding, athletic performance enhancement, or treatment of any medical condition.




Reviews
There are no reviews yet.